These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28965745)

  • 1. The inhibitory effects of biomimetically designed peptides on α-synuclein aggregation.
    Rezaeian N; Shirvanizadeh N; Mohammadi S; Nikkhah M; Arab SS
    Arch Biochem Biophys; 2017 Nov; 634():96-106. PubMed ID: 28965745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complexation of NAC-Derived Peptide Ligands with the C-Terminus of α-Synuclein Accelerates Its Aggregation.
    Jha NN; Ranganathan S; Kumar R; Mehra S; Panigrahi R; Navalkar A; Ghosh D; Kumar A; Padinhateeri R; Maji SK
    Biochemistry; 2018 Feb; 57(5):791-804. PubMed ID: 29286644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A strategy for designing inhibitors of alpha-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders.
    El-Agnaf OM; Paleologou KE; Greer B; Abogrein AM; King JE; Salem SA; Fullwood NJ; Benson FE; Hewitt R; Ford KJ; Martin FL; Harriott P; Cookson MR; Allsop D
    FASEB J; 2004 Aug; 18(11):1315-7. PubMed ID: 15180968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of α-Synuclein Fibril Inhibition by Four Different Amyloid Inhibitors.
    Jha NN; Kumar R; Panigrahi R; Navalkar A; Ghosh D; Sahay S; Mondal M; Kumar A; Maji SK
    ACS Chem Neurosci; 2017 Dec; 8(12):2722-2733. PubMed ID: 28872299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncovering the Binding and Specificity of β-Wrapins for Amyloid-β and α-Synuclein.
    Orr AA; Wördehoff MM; Hoyer W; Tamamis P
    J Phys Chem B; 2016 Dec; 120(50):12781-12794. PubMed ID: 27934063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptides as modulators of α-synuclein aggregation.
    Ruzza P; Gazziero M; Marchi MD; Massalongo G; Marchiani A; Autiero I; Tessari I; Bubacco L; Calderan A
    Protein Pept Lett; 2015; 22(4):354-61. PubMed ID: 25666040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-Amyloid-β Component of Human α-Synuclein Oligomers Induces Formation of New Aβ Oligomers: Insight into the Mechanisms That Link Parkinson's and Alzheimer's Diseases.
    Atsmon-Raz Y; Miller Y
    ACS Chem Neurosci; 2016 Jan; 7(1):46-55. PubMed ID: 26479553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinolinic Acid Amyloid-like Fibrillar Assemblies Seed α-Synuclein Aggregation.
    Tavassoly O; Sade D; Bera S; Shaham-Niv S; Vocadlo DJ; Gazit E
    J Mol Biol; 2018 Oct; 430(20):3847-3862. PubMed ID: 30098337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The C-terminal α-helices of mammalian Hsc70 play a critical role in the stabilization of α-synuclein binding and inhibition of aggregation.
    Chaari A; Eliezer D; Ladjimi M
    Int J Biol Macromol; 2016 Feb; 83():433-41. PubMed ID: 26601760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitroalkylation of α-Synuclein by Nitro-Oleic Acid: Implications for Parkinson's Disease.
    Chavarría C; Trostchansky A; Durán R; Rubbo H; Souza JM
    Adv Exp Med Biol; 2019; 1127():169-179. PubMed ID: 31140178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-Sheet-breaking peptides inhibit the fibrillation of human alpha-synuclein.
    Kim YS; Lim D; Kim JY; Kang SJ; Kim YH; Im H
    Biochem Biophys Res Commun; 2009 Oct; 387(4):682-7. PubMed ID: 19622344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naphthoquinone-Dopamine Hybrids Inhibit α-Synuclein Aggregation, Disrupt Preformed Fibrils, and Attenuate Aggregate-Induced Toxicity.
    Paul A; Huber A; Rand D; Gosselet F; Cooper I; Gazit E; Segal D
    Chemistry; 2020 Dec; 26(69):16486-16496. PubMed ID: 32870550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contact between the β1 and β2 Segments of α-Synuclein that Inhibits Amyloid Formation.
    Shaykhalishahi H; Gauhar A; Wördehoff MM; Grüning CS; Klein AN; Bannach O; Stoldt M; Willbold D; Härd T; Hoyer W
    Angew Chem Int Ed Engl; 2015 Jul; 54(30):8837-40. PubMed ID: 26119103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of short peptide fragments from alpha-synuclein fibril core identifies a residue important for fibril nucleation: a possible implication for diagnostic applications.
    Yagi H; Takeuchi H; Ogawa S; Ito N; Sakane I; Hongo K; Mizobata T; Goto Y; Kawata Y
    Biochim Biophys Acta; 2010 Oct; 1804(10):2077-87. PubMed ID: 20637318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gallic acid interacts with α-synuclein to prevent the structural collapse necessary for its aggregation.
    Liu Y; Carver JA; Calabrese AN; Pukala TL
    Biochim Biophys Acta; 2014 Sep; 1844(9):1481-5. PubMed ID: 24769497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An scFv intrabody against the nonamyloid component of alpha-synuclein reduces intracellular aggregation and toxicity.
    Lynch SM; Zhou C; Messer A
    J Mol Biol; 2008 Mar; 377(1):136-47. PubMed ID: 18237741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxic prefibrillar α-synuclein amyloid oligomers adopt a distinctive antiparallel β-sheet structure.
    Celej MS; Sarroukh R; Goormaghtigh E; Fidelio GD; Ruysschaert JM; Raussens V
    Biochem J; 2012 May; 443(3):719-26. PubMed ID: 22316405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designed hairpin peptides interfere with amyloidogenesis pathways: fibril formation and cytotoxicity inhibition, interception of the preamyloid state.
    Huggins KN; Bisaglia M; Bubacco L; Tatarek-Nossol M; Kapurniotu A; Andersen NH
    Biochemistry; 2011 Sep; 50(38):8202-12. PubMed ID: 21848289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of an N-methylated peptide inhibitor of alpha-synuclein aggregation guided by solid-state NMR.
    Madine J; Doig AJ; Middleton DA
    J Am Chem Soc; 2008 Jun; 130(25):7873-81. PubMed ID: 18510319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computer aided therapeutic tripeptide design, in alleviating the pathogenic proclivities of nocuous α-synuclein fibrils.
    Chandrasekhar G; Srinivasan E; Nandhini S; Pravallika G; Sanjay G; Rajasekaran R
    J Biomol Struct Dyn; 2024; 42(1):483-494. PubMed ID: 36961221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.